Quite possible that some low-level OGD guy told them something and then got overruled by the folks at the FDA.
Maybe it was the janitor.
Given Amphastar’s vicious and directed attacks against Janet Woodcock and other named FDA officials, the fact that Amphastar won’t name the staffer at OGD who called in 2006 to say Lovenox approval was imminent tells me that the story is almost certainly not the whole truth.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”